Aptamers: Design, Theory, and Applications to Diagnosis and Therapy for Diseases

IF 10.7 Q1 MEDICINE, RESEARCH & EXPERIMENTAL
MedComm Pub Date : 2025-05-19 DOI:10.1002/mco2.70180
Sepideh Hassibian, Mahsa Amin, Seyed Mohammad Taghdisi, Elham Sameiyan, Reza Ghaffari, Mona Alibolandi, Mohammad Ramezani, Khalil Abnous, Seyed Mohsen Dehnavi
{"title":"Aptamers: Design, Theory, and Applications to Diagnosis and Therapy for Diseases","authors":"Sepideh Hassibian,&nbsp;Mahsa Amin,&nbsp;Seyed Mohammad Taghdisi,&nbsp;Elham Sameiyan,&nbsp;Reza Ghaffari,&nbsp;Mona Alibolandi,&nbsp;Mohammad Ramezani,&nbsp;Khalil Abnous,&nbsp;Seyed Mohsen Dehnavi","doi":"10.1002/mco2.70180","DOIUrl":null,"url":null,"abstract":"<p>Single-stranded DNA or RNA entities referred to as aptamers exhibit a strong affinity and specificity for attaching to specific targets. Owing to their special properties, which include simplicity of synthesis, low immunogenicity, and adaptability in targeting a variety of substances, these synthetic oligonucleotides have garnered a lot of interest. The function of aptamers can be altered by combining them with complementary oligonucleotides “antidotes,” which are antisense to a particular aptamer sequence. Antidotes play an important role in several fields by specifically targeting the corresponding section of the aptamer. Nevertheless, even with their promising capabilities, the creation of antidotes to regulate or inhibit aptamer function continues to be a relatively unexamined field, constraining their secure and efficient application in medical environments. The review explores experimental methodologies for creating antidotes, the systematic design strategies for managing antidotes in aptamer-based therapies, and their therapeutic efficacy in counteracting disease biomarkers. Additionally, it highlights their diagnostic applications in biosensing and imaging, offering a promising alternative to traditional antibodies. It also investigates the progress, latest innovations, and potential medical uses of aptamer–antidote combinations. Its academic value lies in bridging the gap between theoretical design and practical applications, providing researchers and clinicians with a comprehensive resource to advance aptamer-based solutions in medicine and biotechnology.</p>","PeriodicalId":94133,"journal":{"name":"MedComm","volume":"6 5","pages":""},"PeriodicalIF":10.7000,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mco2.70180","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"MedComm","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/mco2.70180","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Single-stranded DNA or RNA entities referred to as aptamers exhibit a strong affinity and specificity for attaching to specific targets. Owing to their special properties, which include simplicity of synthesis, low immunogenicity, and adaptability in targeting a variety of substances, these synthetic oligonucleotides have garnered a lot of interest. The function of aptamers can be altered by combining them with complementary oligonucleotides “antidotes,” which are antisense to a particular aptamer sequence. Antidotes play an important role in several fields by specifically targeting the corresponding section of the aptamer. Nevertheless, even with their promising capabilities, the creation of antidotes to regulate or inhibit aptamer function continues to be a relatively unexamined field, constraining their secure and efficient application in medical environments. The review explores experimental methodologies for creating antidotes, the systematic design strategies for managing antidotes in aptamer-based therapies, and their therapeutic efficacy in counteracting disease biomarkers. Additionally, it highlights their diagnostic applications in biosensing and imaging, offering a promising alternative to traditional antibodies. It also investigates the progress, latest innovations, and potential medical uses of aptamer–antidote combinations. Its academic value lies in bridging the gap between theoretical design and practical applications, providing researchers and clinicians with a comprehensive resource to advance aptamer-based solutions in medicine and biotechnology.

适配体:疾病诊断和治疗的设计、理论和应用
单链DNA或RNA实体被称为适体,对附着在特定靶标上表现出很强的亲和力和特异性。由于其特殊的性质,包括合成简单、低免疫原性和靶向多种物质的适应性,这些合成的寡核苷酸引起了人们的极大兴趣。适配体的功能可以通过与互补寡核苷酸“解毒剂”结合而改变,“解毒剂”是特定适配体序列的反义。解毒剂通过特异性靶向适配体的相应部分在几个领域发挥重要作用。然而,即使它们具有很好的能力,创造解毒剂来调节或抑制适体功能仍然是一个相对未经研究的领域,限制了它们在医疗环境中的安全和有效应用。这篇综述探讨了创造解毒剂的实验方法,在基于适配体的治疗中管理解毒剂的系统设计策略,以及它们在对抗疾病生物标志物方面的治疗效果。此外,它还强调了它们在生物传感和成像方面的诊断应用,为传统抗体提供了一个有前途的替代品。它还研究了核酸适配体-解毒剂组合的进展、最新创新和潜在的医学用途。它的学术价值在于弥合理论设计和实际应用之间的差距,为研究人员和临床医生提供全面的资源,以推进医学和生物技术中基于适配体的解决方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.70
自引率
0.00%
发文量
0
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信